Mizuho Securities Reiterates Their Buy Rating on Humana (HUM)

Mizuho Securities analyst Ann Hynes reiterated a Buy rating on Humana (HUMResearch Report) on March 8 and set a price target of $500.00. The company’s shares closed last Wednesday at $429.17.

According to TipRanks.com, Hynes is a 5-star analyst with an average return of 11.4% and a 65.7% success rate. Hynes covers the Healthcare sector, focusing on stocks such as Quest Diagnostics, AmerisourceBergen, and Molina Healthcare.

Currently, the analyst consensus on Humana is a Moderate Buy with an average price target of $466.62.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $475.44 and a one-year low of $351.20. Currently, Humana has an average volume of 1.26M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Humana Inc. is a leading health insurance service provider in the United States. The company, through its Retail division, provides medicare benefits and state-based medicaid contracts, which are marketed on a retail basis to individuals. The Group and Specialty business offers employer group commercial fully-insured medical products and specialty health insurance benefits. Humana offers pharmacy solutions, provider services, home-based services, and clinical programs to the company’s health plan members as well as to third parties through the Healthcare Services segment.

Read More on HUM:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More

Latest News Feed